MeiraGTx Holdings (MGTX) Interest & Investment Income (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Interest & Investment Income of $278000.0 for Q4 2025, up 72.67% on a QoQ basis from $161000.0 in Q3 2025, and down 73.06% year-over-year from $1.0 million in Q4 2024.
MeiraGTx Holdings (MGTX) Interest & Investment Income (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $278000.0 for Q4 2025.
- Quarterly Interest & Investment Income fell 73.06% year-over-year to $278000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (down 56.14% YoY) and the FY2025 annual result came in at $1.8 million, down 56.14% from the prior year.
- Interest & Investment Income was $278000.0 for Q4 2025 at MeiraGTx Holdings, up from $161000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.2 million in Q3 2024 and bottomed at $16000.0 in Q1 2022.
- A 5-year average of $461250.0 and a median of $420000.0 in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2021 — Interest & Investment Income tumbled 88.72% — and 2023, when it surged 3306.25%.
- MeiraGTx Holdings' Interest & Investment Income stood at $24000.0 in 2021, then surged by 1700.0% to $432000.0 in 2022, then climbed by 27.08% to $549000.0 in 2023, then surged by 87.98% to $1.0 million in 2024, then tumbled by 73.06% to $278000.0 in 2025.
- Business Quant data shows MGTX's Interest & Investment Income at $278000.0 in Q4 2025, $161000.0 in Q3 2025, and $408000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | MeiraGTx Holdings | 997.33 Mn | 931.40 Mn | - | 278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 408,000.00 |
| Mar 31, 2025 | 971,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 827,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 549,000.00 |
| Sep 30, 2023 | 523,000.00 |
| Jun 30, 2023 | 655,000.00 |
| Mar 31, 2023 | 545,000.00 |
| Dec 31, 2022 | 432,000.00 |
| Sep 30, 2022 | 288,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Jun 30, 2021 | 67,000.00 |
| Mar 31, 2021 | 89,000.00 |